Irritable Bowel Syndrome :: IBS drug Zelmac banned from sale in Australia
Australian health authorities have removed a medicine Zelmac for irritable bowel syndrome (IBS) from sale because of safety concerns.
Cardiovascular disease
Medicine :: Nanocylinders deliver medicine better than nanospheres
Researchers at the University of Pennsylvania School of Medicine & School of Engineering and Applied Science have discovered a better way to deliver drugs to tumors.
Heart Risk :: Ibuprofen may boost heart risk in osteoarthritis patients
The common painkiller, ibuprofen, may boost the likelihood of heart problems in high risk patients who have osteoarthritis, suggests research published ahead of print in the Annals of the Rheumatic Diseases.
Menopause :: No coronary heart disease for newly menopausal women considering hormone therapy
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), provides comment on a re-analysis of pooled data from both hormone therapy arms of the Women?s Health Initiative (WHI) Study published in the Journal of the American Medical Association.
Weight Loss :: Dieting does not work
Will you lose weight and keep it off if you diet? No, probably not, UCLA researchers report in the April issue of American Psychologist, the journal of the American Psychological Association.
Stent :: Boston Scientific announces Japanese approval for the Taxus Express2 stent system
Boston Scientific Corporation announced that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its TAXUS(R) Express2(TM) paclitaxel-eluting coronary stent system in Japan.
Menopause :: Timing of start of hormone therapy may have effect on risk of coronary heart disease
Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease compared to women who begin treatment further from menopause, but researchers did not find this reduced risk was statistically significant, according to a study in the April 4 issue of JAMA.
Sleep :: Sleep disturbance increases spontaneous pain in women
Sleep continuity disturbance impairs endogenous pain-inhibitory function and increases spontaneous pain in women.
Irritable Bowel Syndrome :: Novartis suspends US marketing and sales of Zelnorm
Novartis is complying with a request from the Food and Drug Administration (FDA) to suspend US marketing and sales of Zelnorm (tegaserod maleate), a treatment for irritable bowel syndrome (IBS) with constipation and chronic constipation.
Asthma :: Asthma incidence shows a 50 percent increase in fat people
For overweight and obese individuals, the incidence of asthma increases by 50 percent, as compared to those of normal weight, according to a meta-analysis of seven studies on severe asthma involving 333,102 patients.